(SPNT) Siriuspoint - Overview
Sector: Financial Services | Industry: Insurance - Reinsurance | Exchange: NYSE (USA) | Market Cap: 2.699m USD | Total Return: 21.8% in 12m
Avg Turnover: 16.2M
EPS Trend: 52.3%
Qual. Beats: 0
Rev. Trend: 66.9%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
SiriusPoint Ltd. (NYSE: SPNT) is a Bermuda-based provider of multi-line insurance and reinsurance services. The company operates through four distinct segments: Global P&C Programs, Global Reinsurance, Global Accident & Health, and London Market Specialty. Its portfolio covers a broad range of risks, including casualty, property, marine, energy, aviation, and credit, while also offering niche products such as medical travel insurance and emergency assistance services.
The reinsurance business model primarily involves assuming portions of risk from other insurance companies to stabilize their capital requirements and protect against catastrophic losses. As a property and casualty (P&C) specialist, SiriusPoint utilizes both treaty and facultative reinsurance structures to manage exposure across global markets. Formerly known as Third Point Reinsurance Ltd., the firm rebranded in 2021 following a significant merger to expand its underwriting capacity and global distribution footprint.
Investors can evaluate the underlying performance metrics of this firm by reviewing the data on ValueRay. SiriusPoint remains focused on diversifying its underwriting portfolio to mitigate volatility inherent in the specialty insurance sector.
- Underwriting profitability improvements in Global Reinsurance segment drive net income growth
- Strategic shift toward MGA partnerships enhances fee-based revenue and margins
- Catastrophe loss exposure and reinsurance pricing cycles impact capital adequacy
- Investment portfolio performance remains sensitive to interest rate and credit volatility
- Regulatory oversight in Bermuda and London affects capital allocation and dividends
| Net Income: 500.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.79 > 1.0 |
| NWC/Revenue: 94.31% < 20% (prev -59.03%; Δ 153.3% < -1%) |
| CFO/TA 0.03 > 3% & CFO 326.9m > Net Income 500.2m |
| Net Debt (-2.30b) to EBITDA (589.0m): -3.91 < 3 |
| Current Ratio: 1.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (121.8m) vs 12m ago -24.50% < -2% |
| Gross Margin: 45.53% > 18% (prev 0.26%; Δ 4.53k% > 0.5%) |
| Asset Turnover: 26.11% > 50% (prev 21.61%; Δ 4.50% > 0%) |
| Interest Coverage Ratio: 7.49 > 6 (EBITDA TTM 589.0m / Interest Expense TTM 78.4m) |
| A: 0.24 (Total Current Assets 8.37b - Total Current Liabilities 5.32b) / Total Assets 12.5b |
| B: 0.11 (Retained Earnings 1.33b / Total Assets 12.5b) |
| C: 0.05 (EBIT TTM 587.5m / Avg Total Assets 12.4b) |
| D: 0.13 (Book Value of Equity 1.35b / Total Liabilities 10.2b) |
| Altman-Z'' = 2.41 = A |
As of May 23, 2026, the stock is trading at USD 23.53 with a total of 913,322 shares traded.
Over the past week, the price has changed by +1.57%,
over one month by -0.85%,
over three months by +12.39% and
over the past year by +21.84%.
Siriuspoint has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold SPNT.
- StrongBuy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 27 | 14.7% |
P/E Forward = 9.3458
P/S = 0.8907
P/B = 1.1972
Revenue TTM = 3.23b USD
EBIT TTM = 587.5m USD
EBITDA TTM = 589.0m USD
Long Term Debt = 688.6m USD (from longTermDebt, last fiscal year)
Short Term Debt = 5.10m USD (from shortTermDebt, last quarter)
Debt = 702.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.30b USD (calculated: Debt 702.9m - CCE 3.01b)
Enterprise Value = 396.4m USD (2.70b + Debt 702.9m - CCE 3.01b)
Interest Coverage Ratio = 7.49 (Ebit TTM 587.5m / Interest Expense TTM 78.4m)
EV/FCF = 0.71x (Enterprise Value 396.4m / FCF TTM 555.6m)
FCF Yield = 140.2% (FCF TTM 555.6m / Enterprise Value 396.4m)
FCF Margin = 17.18% (FCF TTM 555.6m / Revenue TTM 3.23b)
Net Margin = 15.47% (Net Income TTM 500.2m / Revenue TTM 3.23b)
Gross Margin = 45.53% ((Revenue TTM 3.23b - Cost of Revenue TTM 1.76b) / Revenue TTM)
Gross Margin QoQ = 53.15% (prev 61.77%)
Tobins Q-Ratio = 0.03 (Enterprise Value 396.4m / Total Assets 12.5b)
Interest Expense / Debt = 11.15% (Interest Expense 78.4m / Debt 702.9m)
Taxrate = 15.80% (19.2m / 121.5m)
NOPAT = 494.7m (EBIT 587.5m * (1 - 15.80%))
Current Ratio = 1.24 (Total Current Assets 8.37b / Total Current Liabilities 6.77b)
Debt / Equity = 0.31 (Debt 702.9m / totalStockholderEquity, last quarter 2.30b)
Debt / EBITDA = -3.91 (Net Debt -2.30b / EBITDA 589.0m)
Debt / FCF = -4.14 (Net Debt -2.30b / FCF TTM 555.6m)
Total Stockholder Equity = 2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 500.2m / Total Assets 12.5b)
RoE = 22.02% (Net Income TTM 500.2m / Total Stockholder Equity 2.27b)
RoCE = 19.84% (EBIT 587.5m / Capital Employed (Equity 2.27b + L.T.Debt 688.6m))
RoIC = 6.90% (NOPAT 494.7m / Invested Capital 7.17b)
WACC = 7.27% (E(2.70b)/V(3.40b) * Re(6.72%) + D(702.9m)/V(3.40b) * Rd(11.15%) * (1-Tc(0.16)))
Discount Rate = 6.72% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -72.17 | Cagr: -14.56%
[DCF] Terminal Value 77.97% ; FCFF base≈414.7m ; Y1≈475.4m ; Y5≈699.7m
[DCF] Fair Price = 109.2 (EV 10.5b - Net Debt -2.30b = Equity 12.8b / Shares 117.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 52.26 | EPS CAGR: 37.35% | SUE: 0.06 | # QB: 0
Revenue Correlation: 66.88 | Revenue CAGR: 5.61% | SUE: -0.03 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.66 | Chg30d=-2.84% | Revisions=-20% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.60 | Chg30d=+3.61% | Revisions=+33% | Analysts=4
EPS current Year (2026-12-31): EPS=2.56 | Chg30d=-0.58% | Revisions=-20% | GrowthEPS=+0.2% | GrowthRev=-2.4%
EPS next Year (2027-12-31): EPS=2.77 | Chg30d=-1.25% | Revisions=-20% | GrowthEPS=+8.2% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: +33%